tradingkey.logo
tradingkey.logo
Search

Envoy Medical Inc

COCH
Add to Watchlist
0.671USD
+0.004+0.62%
Close 07-31 16:00ETQuotes delayed by 15 min
15.97MMarket Cap
LossP/E TTM

COCH Income Statement

You can find the annual or quarterly income statement of Envoy Medical Inc here for insights into the performance and operational efficiency of Envoy Medical Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Total revenue
-15.22%39.00K
78.57%75.00K
-25.00%42.00K
14.71%78.00K
-22.03%46.00K
-55.79%42.00K
-30.00%56.00K
7.94%68.00K
-24.36%59.00K
375.00%95.00K
40.35%80.00K
6.78%63.00K
-22.77%78.00K
--20.00K
--57.00K
--59.00K
--101.00K
Revenue
-15.22%39.00K
78.57%75.00K
-25.00%42.00K
14.71%78.00K
-22.03%46.00K
-55.79%42.00K
-30.00%56.00K
7.94%68.00K
-24.36%59.00K
375.00%95.00K
40.35%80.00K
6.78%63.00K
-22.77%78.00K
--20.00K
--57.00K
--59.00K
--101.00K
Cost of revenue
38.50%313.00K
34.39%211.00K
8.56%203.00K
-4.49%234.00K
47.71%226.00K
-32.91%157.00K
-1.06%187.00K
-26.43%245.00K
-47.96%153.00K
-61.64%234.00K
78.30%189.00K
52.75%333.00K
38.03%294.00K
--610.00K
--106.00K
--218.00K
--213.00K
Operating expenses
16.40%6.00M
41.48%6.46M
14.31%5.75M
4.46%5.15M
4.25%5.15M
-33.03%4.57M
45.17%5.03M
8.47%4.93M
28.42%4.94M
133.01%6.82M
86.99%3.46M
101.64%4.54M
101.41%3.85M
--2.93M
--1.85M
--2.25M
--1.91M
R&D expenses
32.53%3.64M
84.26%4.55M
-2.07%2.70M
-4.09%2.48M
16.44%2.75M
-19.12%2.47M
49.03%2.76M
30.79%2.59M
30.46%2.36M
210.47%3.06M
97.86%1.85M
45.55%1.98M
72.94%1.81M
--984.00K
--935.00K
--1.36M
--1.05M
Depreciation, depletion, and amortization
19.67%73.00K
66.67%80.00K
55.10%76.00K
102.38%85.00K
79.41%61.00K
0.00%48.00K
68.97%49.00K
44.83%42.00K
25.93%34.00K
84.62%48.00K
31.82%29.00K
107.14%29.00K
107.69%27.00K
--26.00K
--22.00K
--14.00K
--13.00K
Operating profit
-16.68%-5.96M
-41.14%-6.38M
-14.76%-5.71M
-4.32%-5.07M
-4.57%-5.11M
32.71%-4.52M
-46.94%-4.97M
-8.48%-4.86M
-29.51%-4.88M
-131.35%-6.72M
-88.47%-3.38M
-104.19%-4.48M
-108.34%-3.77M
---2.91M
---1.80M
---2.19M
---1.81M
Net non-operating interest income (expenses)
Non-operating interest expense
-100.00%0.00
-100.00%0.00
78.41%471.00K
372.73%624.00K
1275.00%495.00K
--384.00K
--264.00K
--132.00K
--36.00K
----
----
----
----
----
----
----
----
Special income (expenses)
160.49%1.60M
-155.89%-185.00K
58.21%-308.00K
-99.52%5.00K
146.03%615.00K
-80.70%331.00K
-115.03%-737.00K
111.92%1.04M
85.75%-1.34M
120.03%1.71M
754.01%4.90M
-1014.08%-8.77M
-15528.33%-9.38M
---8.56M
--574.00K
--959.00K
---60.00K
Other non-operating income (expenses)
154.55%6.00K
60.98%-16.00K
-66.67%5.00K
---1.00K
21.43%-11.00K
-136.28%-41.00K
-67.39%15.00K
--0.00
86.67%-14.00K
1512.50%113.00K
139.32%46.00K
100.00%0.00
-10400.00%-105.00K
---8.00K
---117.00K
---1.00K
---1.00K
Income before tax
12.95%-4.35M
-42.62%-6.59M
-8.76%-6.48M
-44.16%-5.69M
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Income tax
----
--0.00
----
----
----
--0.00
----
----
----
--0.00
----
----
----
----
----
----
----
Income after tax
12.95%-4.35M
-42.62%-6.59M
-8.76%-6.48M
-44.16%-5.69M
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Net income from continuous operations
12.95%-4.35M
-42.62%-6.59M
-8.76%-6.48M
-44.16%-5.69M
20.29%-5.00M
5.66%-4.62M
-481.32%-5.96M
70.20%-3.95M
52.69%-6.27M
57.35%-4.89M
216.73%1.56M
-971.68%-13.25M
-608.34%-13.25M
---11.48M
---1.34M
---1.24M
---1.87M
Net income attributable to controlling interests
8.58%-5.70M
-0.66%-7.74M
-5.54%-7.75M
-30.69%-6.94M
18.32%-6.24M
-23.09%-7.69M
-639.71%-7.34M
61.36%-5.31M
44.48%-7.63M
45.60%-6.24M
201.57%1.36M
-691.82%-13.75M
-480.05%-13.75M
---11.48M
---1.34M
---1.74M
---2.37M
Preferred share dividend
9.05%1.35M
-62.48%1.15M
-8.33%1.26M
-8.28%1.25M
-9.30%1.24M
127.43%3.07M
579.80%1.38M
173.00%1.36M
173.00%1.36M
--1.35M
--203.00K
0.00%500.00K
0.00%500.00K
----
----
--500.00K
--500.00K
Net income attributable to common shareholders
8.58%-5.70M
-0.66%-7.74M
-5.54%-7.75M
-30.69%-6.94M
18.32%-6.24M
-23.09%-7.69M
-639.71%-7.34M
61.36%-5.31M
44.48%-7.63M
45.60%-6.24M
201.57%1.36M
-691.82%-13.75M
-480.05%-13.75M
---11.48M
---1.34M
---1.74M
---2.37M
Basic earnings per share
71.72%-0.08
42.21%-0.27
5.25%-0.35
-19.78%-0.32
28.77%-0.29
-40.99%-0.47
-381.02%-0.37
61.45%-0.27
41.65%-0.41
43.19%-0.33
294.41%0.13
-691.80%-0.70
-480.05%-0.70
---0.59
---0.07
---0.09
---0.12
Diluted earnings per share
71.72%-0.08
42.21%-0.27
5.25%-0.35
-19.78%-0.32
28.77%-0.29
-40.99%-0.47
-398.89%-0.37
61.45%-0.27
41.65%-0.41
43.19%-0.33
282.79%0.13
-691.80%-0.70
-480.05%-0.70
---0.59
---0.07
---0.09
---0.12
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Envoy Medical Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing COCH stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Envoy Medical Inc's revenue at year end?

Envoy Medical Inc reported 241.00K in revenue for fiscal year 2025, up from 225.00K in the previous year.

How much revenue did Envoy Medical Inc report in the most recent quarter?

Envoy Medical Inc reported 39.00K in revenue for the most recent quarter, an increase of -15.22% year over year.

What was Envoy Medical Inc's net income for the year?

Envoy Medical Inc posted -28.66M in net income for fiscal year 2025.

How much net income did Envoy Medical Inc post in the last quarter?

Envoy Medical Inc reported -5.70M in net income for the latest quarter。

What was Envoy Medical Inc's annual operating profit?

Envoy Medical Inc's operating income was -22.27M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.